Compare American Well Corp (AMWL) vs Philip Morris International Inc. (PM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
American Well Corp vs Philip Morris International Inc. — how do they compare? American Well Corp trades at $9.9 (market cap $165.58M), while Philip Morris International Inc. trades at $182.77 (market cap $283.07B). The key difference: Philip Morris International Inc. is far larger — about 1709.6× American Well Corp's market cap, and Philip Morris International Inc. pays a 3.24% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | PM | |
|---|---|---|
Market Cap | $165.58M | $283.07B |
Sector | Health | Consumer Staples |
52-Week High | $9.91 | $191.86 |
52-Week Low | $3.78 | $144.33 |
Enterprise Value | -$9.66M | $329.56B |
Dividend Yield | — | 3.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
Philip Morris International (PM) trades at $181.62, up 0.25% today, near the analyst consensus price target of $194. The stock shows a bullish technical trend with support at $179 and resistance at $185. Recent Q1 2026 earnings beat expectations at $1.96 EPS versus $1.86, though Q4 2025 missed. Revenue grew to $40.65B in 2025 with a strong net margin of 26.74%. The company announced a $1.47 dividend payable July 20, 2026, but cut its 2026 profit forecast due to a $500M impairment and cost pressures.
Outlook remains positive with 68% analyst buy ratings, but risks include rising illicit cigarette trade in Europe, currency volatility, and consumer spending constraints. The stock offers value with a P/E of 25.57 and stable cash flows, though high debt levels and regulatory challenges require monitoring for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →
